Atlas Trials

Protectivity and Safety Following Recombinant Hepatitis B Vaccine

Clinical trial NCT03919578 · COMPLETED

Trial details

NCT number
NCT03919578
Sponsor
PT Bio Farma
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Immunogenicity
Start date
2019-09-11
Primary completion
2020-01-30
Enrollment
536

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.